migraines

Showing 1 - 14 of 14

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Migraines Trial in London (occipital nerve stimulator)

Recruiting
  • Migraines
  • occipital nerve stimulator
  • London, United Kingdom
    Barts health NHS Trust
Sep 1, 2023

Vestibulodynia, Temporomandibular Disorder, Fibromyalgia Syndrome Trial in Los Angeles, Chapel Hill (5% lidocaine/5 mg/ml 0.02%

Recruiting
  • Vestibulodynia
  • +9 more
  • 5% lidocaine/5 mg/ml 0.02% estradiol compound cream
  • +3 more
  • Los Angeles, California
  • +1 more
Nov 16, 2021

Migraines Trial in Manchester (Part A: TRV250-20mg/ml, Placebo, Part B: TRV250 Dose 1)

Terminated
  • Migraines
  • Part A: TRV250-20mg/ml
  • +4 more
  • Manchester, Greater Mancherster, United Kingdom
    MAC Clinical Research Manchester (Early Phase Unit), Neuroscienc
Sep 20, 2021

Migraines Trial in Winston-Salem (Questionnaires, Quantitative Sensory Testing (QST) Pain Measurements)

Completed
  • Migraines
  • Questionnaires
  • Quantitative Sensory Testing (QST) Pain Measurements
  • Winston-Salem, North Carolina
    Wake Forest University Health Sciences
May 8, 2020

Children With Cyclic Vomiting Syndrome (CVS) and Migraines

Completed
  • Vomiting
  • Migraines
    • Milwaukee, Wisconsin
      Children's Hospital of Wisconsin
    Dec 23, 2019

    Understudied Drugs Administered to Children Per Standard of Care

    Completed
    • Adenovirus
    • +58 more
    • The POPS study is collecting PK data on children prescribed the following drugs of interest per standard of care:
    • Anchorage, Alaska
    • +51 more
    Dec 18, 2019

    Epilepsy, Migraines Trial in Minneapolis (intravenous topiramate)

    Completed
    • Epilepsy
    • Migraines
    • intravenous topiramate
    • Minneapolis, Minnesota
      University of Minnesota
    Jul 15, 2019

    Migraines Trial in Leuven (LY2951742, Placebo)

    Completed
    • Migraines
    • Leuven, Belgium
      For additional information regarding investigative sites for thi
    Oct 8, 2018

    Migraines Trial (Telcagepant 140 mg, Talcagepant 280 mg, Placebo)

    Completed
    • Migraines
    • Telcagepant 140 mg
    • +2 more
    • (no location specified)
    Sep 18, 2018

    Migraines Trial in Baltimore (Ketorolac, Sumatriptan, Placebo)

    Completed
    • Migraines
    • Baltimore, Maryland
      The Johns Hopkins Bayview Headache Center
    Mar 10, 2017

    Migraines Trial in Washington (Plant based diet, an unrestricted diet)

    Completed
    • Migraines
    • Plant based diet
    • an unrestricted diet
    • Washington, District of Columbia
      Physicians Committee for Responsible Medicine
    Oct 19, 2015

    Childhood Depression, Childhood Anxiety, Pediatric Pain Trial in Durham (Integrative Coping Group)

    Completed
    • Childhood Depression
    • +6 more
    • Integrative Coping Group
    • Durham, North Carolina
      Duke Child and Family Study Center
    Aug 19, 2014

    Migraines Trial in Washington (Vegan Diet, mixture of omega3 and vitamins)

    Completed
    • Migraines
    • Vegan Diet
    • mixture of omega3 and vitamins
    • Washington, District of Columbia
      Physicians Committee for Responsible Medicine
    May 13, 2013

    Migraines Trial in North Chicago (divalproex sodium)

    Completed
    • Migraines
    • divalproex sodium
    • North Chicago, Illinois
      Global Medical Information - Abbott
    Jul 30, 2007